Literature DB >> 30731326

Transvenous embolization of arteriovenous malformations.

George Zaki Ghali1, Michael George Zaki Ghali2, Emil Zaki Ghali3.   

Abstract

Embolization of arteriovenous malformations is characteristically used as part of a multimodal treatment approach, pre-operatively to facilitate microsurgical resection or as a preradiosurgical adjunct. The concept of AVM cure via embolization alone has gained popularity in recent years. Embolization of AVMs has been most commonly performed transarterially, with the transvenous route traditionally eschewed given concern over precipitating premature venous occlusion and consequent hemorrhage. However, the transvenous approach in treating AVMs offers several distinct advantages compared to the transarterial route and can be used in instances when the latter is not feasible, with several series having proven its efficacy and safety. Conceptually, AVM embolization performed via the transvenous route achieves complete obliteration by directly and facilely targeting the nidus. Nidal embolisate penetration is facilitated by control of arterial inflow via systemic or local hypotension. Innovation in endovascular strategies has led to significantly improved obliteration rates. The experience with transvenous AVM embolization is reviewed and discussed.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  AVMs; Arteriovenous malformations; Curative; Embolization; Transvenous

Mesh:

Year:  2018        PMID: 30731326     DOI: 10.1016/j.clineuro.2018.08.024

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

Review 1.  Sphenoid dural arteriovenous fistulas.

Authors:  Michael George Zaki Ghali
Journal:  Neurosurg Rev       Date:  2019-12-07       Impact factor: 3.042

2.  Multimodal Treatment of Pediatric Ruptured Brain Arteriovenous Malformations: A Single-Center Study.

Authors:  Lukasz Antkowiak; Monika Putz; Marta Rogalska; Marek Mandera
Journal:  Children (Basel)       Date:  2021-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.